Review



multi-platform profiling with organoid drug sensitivity screening and ctdna monitoring  (Natera Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Natera Inc multi-platform profiling with organoid drug sensitivity screening and ctdna monitoring
    Summary of Clinical Trials of drug sensitivity with <t> organoid </t> methods.
    Multi Platform Profiling With Organoid Drug Sensitivity Screening And Ctdna Monitoring, supplied by Natera Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/multi-platform profiling with organoid drug sensitivity screening and ctdna monitoring/product/Natera Inc
    Average 90 stars, based on 1 article reviews
    multi-platform profiling with organoid drug sensitivity screening and ctdna monitoring - by Bioz Stars, 2026-02
    90/100 stars

    Images

    1) Product Images from "Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank"

    Article Title: Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank

    Journal: Frontiers in Oncology

    doi: 10.3389/fonc.2021.762184

    Summary of Clinical Trials of drug sensitivity with organoid methods.
    Figure Legend Snippet: Summary of Clinical Trials of drug sensitivity with organoid methods.

    Techniques Used: Clinical Proteomics, Mutagenesis, Diagnostic Assay, Sampling, In Vitro, High Throughput Screening Assay, Functional Assay, Sequencing, Comparison



    Similar Products

    multi-platform profiling with organoid drug sensitivity screening and ctdna monitoring  (Natera Inc)
    90
    Natera Inc multi-platform profiling with organoid drug sensitivity screening and ctdna monitoring
    Summary of Clinical Trials of drug sensitivity with <t> organoid </t> methods.
    Multi Platform Profiling With Organoid Drug Sensitivity Screening And Ctdna Monitoring, supplied by Natera Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/multi-platform profiling with organoid drug sensitivity screening and ctdna monitoring/product/Natera Inc
    Average 90 stars, based on 1 article reviews
    multi-platform profiling with organoid drug sensitivity screening and ctdna monitoring - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Summary of Clinical Trials of drug sensitivity with organoid methods.

    Journal: Frontiers in Oncology

    Article Title: Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank

    doi: 10.3389/fonc.2021.762184

    Figure Lengend Snippet: Summary of Clinical Trials of drug sensitivity with organoid methods.

    Article Snippet: Biliary Tract Cancer , Tumor resection , Multi-Platform Profiling with Organoid Drug Sensitivity Screening and ctDNA Monitoring , 20 , September 23, 2020 , Sponsor: University of Washington Collaborators: Natera, Inc. SEngine Precision Medicine, Inc. , NCT04561453/ Recruiting.

    Techniques: Clinical Proteomics, Mutagenesis, Diagnostic Assay, Sampling, In Vitro, High Throughput Screening Assay, Functional Assay, Sequencing, Comparison